Klaviyo, Inc. (KVYO): what the price assumes

In the published model solve dated 2026-Q2, anchored at $19.40, Klaviyo, Inc. (KVYO) is priced for +16.8% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/KVYO

Headline

FieldValue
TickerKVYO
CompanyKlaviyo, Inc.
Current price$19.40/sh
CompositionUnited States 60% / Other Americas 5% / APAC 10% / EMEA - United Kingdom 10% / EMEA - Other 15%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisrevenue-multiple
EV / sales paid3.9x
Steady-state operating margin assumed29.9%
Implied growth16.8%

The company earns no operating profit yet; the inversion runs on the revenue multiple and an assumed steady-state margin.

Solve inputs: computed at a 11.7% cost of capital with 4% terminal growth over a 5-year stage, holding a 29.9% terminal operating margin (74.7% gross margin x the 40% mature-conversion prior); each 1pp of cost of capital moves the implied revenue growth ~6pp.

Reconcile: at the x-ray's 9.3% required return this reads ~3%/yr; the models below use their own rates.

How unusual the bet is: within-range

ReferenceValue
vs own history-2.51σ
sustained it ~5 years at this level48%
implied end-window share0%

Valuation X-Ray

The price is justified by relative-multiple and growth-DCF; asset-based/earnings-power land below the price.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset5.43x2expensive
Earnings3.14x2expensive
Relative0.57x2justifies
Growth0.55x3justifies

Families that justify the price: Relative, Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.1%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$35.030.55xyesFCF base $0.3B, growth 25% (input: historical growth), terminal g 4.0%, WACC 9.1%, 7yr projection
DCF Exit MultipleGrowth$0.00—noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$34.330.57xyesP/S fallback (negative EPS): Sector P/S 8.0x × TTM revenue — excluded from consensus
Simple DDMGrowth——no—
Two-Stage DDMGrowth——no—
Simple Excess ReturnAsset$3.775.15xyesBook value floor: BV/sh $3.77, ROE negative
Two-Stage Excess ReturnAsset$3.395.72xyesBook value with convergence: BV/sh $3.77, ROE converges to ke
Discounted Future Market CapGrowth$28.150.69xyesRev $1.3B, growth 30% (input: historical growth; tapered), Terminal P/S: 3.6x / 4.5x / 5.4x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00—noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowth$39.130.50xyesMargin ramp: -1% → 22% over 7yr, rev growth 30% (input: historical growth; tapered)
Earnings Power ValueEarnings——no—
Residual IncomeAsset——no—
Graham NumberAsset——no—
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings$10.271.89xyesFCF $219.5M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$4.424.39xyesSBC-adj FCF $0.05B (FCF $0.22B − SBC $0.17B) capitalized at Kₑ
Ben Graham FormulaEarnings——no—
ROIC-Justified P/BAsset$0.16121.25xyesBV $3.77 × (ROIC 0.4% / WACC 9.1%) (excluded from median)
P/Sales SectorRelative$34.330.57xyesRevenue $1.31B × sector P/S 8.0x
PEG Fair ValueRelative——no—
Earnings YieldEarnings——no—
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Net cash$984.6m
Share count CAGR (dilution)8.2%
Burning cashno

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

Bull Case

The gap between what the price is pricing in and what the business is delivering is the bull case in one sentence. At roughly 2.6 times revenue, the stock embeds an assumption that revenue essentially stops growing while margins mature, yet Klaviyo grew revenue 28% to $358.0 million in the most recent quarter. The market is pricing a near-stall; the company is compounding at nearly 30%. When the fundamentals are growing several times faster than the price implies, the burden of proof shifts: the stock does not need a heroic outcome to work, it only needs growth to keep beating the flat-line assumption baked into the price.

The business model is a high-margin, sticky software platform, which is what makes the eventual-margin assumption achievable. The platform monetizes a merchant's own customer data across email and SMS, and the 10-K notes Klaviyo pays customer-acquisition costs like sales commissions on the initial contract that it then benefits from "for more than one year," the classic SaaS dynamic where the cost is front-loaded and the revenue recurs. Gross margin runs in the mid-70s, and dollar-based net revenue retention of 110% means existing customers spend more each year, so the base grows even before a single new logo is added. The customer count surpassed 196,000, with growth in enterprise-tier accounts and international markets, which is the move from small-merchant tool toward a platform large brands standardize on.

Profitability has arrived, and the balance sheet removes the survival question. Klaviyo turned GAAP-profitable in the quarter with net income of $9.0 million, reversing a year-earlier loss, posted its best operating margin since going public, and raised full-year revenue guidance. It holds roughly $985 million in cash against no debt, so it funds growth and a newly announced buyback internally. The AI products, Composer and a Customer Agent, are accelerating adoption, and the company has expanded an integration with Anthropic to bring agentic marketing workflows to Claude. Against software peers like Workiva and Semrush, Klaviyo pairs faster growth with improving margins and a cash-rich balance sheet, and the bull case is simply that the price assumes a stall the numbers are not showing.

Bear Case

The governance and capital-allocation concern a holder should weigh first is dilution: Klaviyo's share count has been growing more than 8% a year, which means stock-based compensation is quietly transferring ownership from existing holders to employees. A company can post GAAP net income of $9.0 million while issuing stock fast enough to dilute holders 8% annually, and the bear's point is that the headline profitability flatters a picture where per-share value is being eroded by the equity used to pay the workforce. The newly announced $500 million buyback is, in part, a buyback to offset that dilution rather than to return capital, which is a different and less generous thing than it sounds. For an unprofitable-until-recently software company, the real economic profit is net income after the true cost of the equity it hands out, and that number is far thinner than the GAAP line.

The competitive position is more contested than the growth rate suggests. The 10-K is candid that Klaviyo expects to "encounter new competitors, which may include any of our current or future third-party platform providers or technology partners," a pointed acknowledgment that the very platforms Klaviyo integrates with, the ecommerce and commerce infrastructure providers, could build or buy competing functionality. Klaviyo's growth has leaned heavily on the small and mid-market merchant base tied to ecommerce platforms, and the move upmarket into enterprise puts it against larger, entrenched marketing-cloud vendors. Net revenue retention of 110% is healthy but not exceptional for software, and a deceleration there, combined with platform-partner competition, is the scenario that turns 28% growth into the near-flat trajectory the price already half-assumes.

The macro and structural sensitivity is the ecommerce cycle itself. Klaviyo's revenue scales with its merchants' marketing spend, which scales with their sales, so a consumer pullback that pressures online retailers flows straight through to Klaviyo's usage-linked revenue, and the company notes its SMS channel adds seasonality on top. The current operating margin is still slim, with trailing GAAP operating profit modestly negative on a record basis, so the eventual high-20s margin the price assumes is a destination, not a current reality. If retention slips or ecommerce spend softens, the path to that margin lengthens, and a stock whose justification rests on growth durability gets repriced quickly when the growth durability is the thing in question.

Valuation

Because Klaviyo is only just GAAP-profitable, the price is set against its sales rather than its earnings, and on that basis the assumption embedded is strikingly conservative. At about 2.6 times revenue, the price implies the business eventually earns an operating margin near 30% while revenue grows essentially not at all, roughly flat over the forecast. Set that against a company growing revenue 28% and you see the tension: the market is underwriting a near-stall, and the recent results contradict it. The eventual-margin assumption, a high-20s operating margin, is plausible for a mid-70s-gross-margin software platform at scale, so the live question is durability of growth, not whether the margin is reachable.

The method families split the way they do for a profitable-at-the-edge software name. The relative-multiple lens and the growth-oriented cash-flow lens both support the price, while the asset-value and earnings-power lenses read it as expensive, sitting well above where book value and current near-zero earnings land. That pattern is expected: a software company has little tangible asset value and minimal current earnings to capitalize, so those lenses structurally read low, while the revenue multiple and the forward-growth view, which credit the recurring revenue base, support the price. The relative lens supporting the price at a low revenue multiple is the signal that the stock is not richly valued against its own sales.

Solvency is a clear strength and removes the existential risk that hangs over many software names at this stage. Klaviyo holds roughly $985 million in cash against no debt, so it can fund growth, the AI product buildout, and a $500 million buyback without external capital. The valuation rests not on survival but on whether growth holds long enough to grow into the margin the price assumes, and the dilution from stock-based compensation is the offsetting drag the buyback is partly meant to absorb. Against software peers Workiva and Semrush, Klaviyo grows faster at a comparable-to-lower revenue multiple, and the analyst mean target near $29 to $37 sits far above today's price. That unusually wide gap between the street targets and the price is the read: the market price embeds a near-stall the analysts and the recent growth both reject, which makes the durability of that 28% growth the entire bet.

Catalysts

The first-quarter 2026 print, reported in early May, beat and lifted the outlook. Klaviyo posted revenue of $358.0 million, up 28% year over year, with GAAP net income of $9.0 million reversing a year-earlier loss, GAAP EPS of $0.22 ahead of the $0.20 expectation, and dollar-based net revenue retention of 110%. Management raised full-year 2026 revenue guidance to a range of $1.514 billion to $1.522 billion, roughly 23% growth, and the customer base passed 196,000 with revenue per full-time employee above $600,000. The combination of accelerating profitability and a raised top-line outlook is what drove a positive reaction.

Capital return and product are the forward catalysts. Alongside the results, Klaviyo launched a $500 million share repurchase program, its first, which is intended in part to offset stock-based-compensation dilution. On product, its AI tools Composer and Customer Agent are accelerating adoption, and the company expanded an integration with Anthropic to bring agentic marketing workflows to Claude. Whether these AI features lift retention and average revenue per customer is the operating catalyst to watch.

The sell side is markedly more bullish than the price. The consensus rating sits at Buy to Strong Buy, with a mean price target near $29 to $37, well above today's price, and a range from roughly $17 to $37. That wide gap between targets and the current price reflects the disconnect at the heart of the name: the stock trades as if growth is about to stall, while the analysts and the recent prints point to continued mid-20s growth, and the next retention and guidance update is the data point that resolves it.

Peer Cohorts (Per Segment, With Filing Citations)

Klaviyo (single segment) (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Klaviyo Q1 2026 results, May 2026 · Klaviyo Q1 2026 product update, 2026 · Klaviyo share-count data, 2026 · MarketBeat and Benzinga analyst consensus, 2026 · Klaviyo 2026 guidance, May 2026 · Klaviyo Q1 2026 buyback announcement, May 2026 · MarketBeat and Benzinga analyst coverage, 2026

View the full interactive KVYO report on boothcheck